The fight once morest Alzheimer’s disease continues to intensify. Researchers from the Institute of Psychiatry, Psychology and Neurosciences at King’s College London (UK) are working on a new blood test capable of detecting the onset of this neurodegenerative disease. Their results are published in Brain magazine.
To carry out their research, the specialists took blood samples from a panel of 56 patients with cognitive disorders mild (MCI), at a follow-up ranging from 2 to 5 years. These disorders are characterized by deterioration of memory and cognitive abilities. While not everyone with these disorders is automatically affected by Alzheimer’s disease, 36 of the participants developed it. “In our study, we treated brain cells with blood taken from people with MCI, to investigate how these cells change in response to blood as Alzheimer’s disease is progressing”, explains Dr. Aleksandra Maruszak, one of the first authors of the study in a press release. Until now, this test was carried out during an autopsy following the death of the patient, this is the first time that it is carried out on living patients.
Starting point of this test, the blood would have an impact on the neurogenèse, namely the creation of new brain cells. This process is particularly important in the region of the hippocampus, an area of the brain that directly impacts (…)
